Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
No open-market purchases or sales by Processa Pharmaceuticals, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 372.6K | 1.78M | +1.41M (+377.9%) |
| Value | $75.9K | $341.9K | +$266.0K (+350.4%) |
New holders (7)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,030,200 | $197.7K | 0.16% |
| Two Sigma Securities, LLC | 36,248 | $6.96K | 0.00% |
| Citigroup Inc | 34,051 | $6.53K | 0.00% |
| StoneX Group Inc. | 18,951 | $3.64K | 0.00% |
| Sassicaia Capital Advisers LLC | 15,977 | $3.07K | 0.00% |
| Miracle Mile Advisors, LLC | 10,000 | $1.92K | 0.00% |
| Jones Financial Companies LLLP | 188 | $40 | 0.00% |
Sold out (6)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| UBS Group AG | 64,612 | $13.2K |
| Alpine Global Management, LLC | 53,416 | $10.9K |
| Cubist Systematic Strategies, LLC | 41,848 | $8.58K |
| Jane Street Group, LLC | 19,270 | $3.95K |
| Sequoia Financial Advisors, LLC | 11,000 | $2.25K |
| SBI Securities Co., Ltd. | 12 | $2 |